Significant Increase in Short Positions
According to the latest FINRA short interest data for the settlement date of September 15, 2026, Teva Pharmaceutical Industries (TEVA) has experienced a dramatic increase in short interest. The data indicates that short positions have risen more than tenfold compared to the previous reporting period. While FINRA data is published on a twice-monthly basis and carries an inherent lag, this magnitude of increase is a notable signal for market participants monitoring institutional bearish sentiment.
Understanding the Data
It is critical to distinguish that this figure represents official open short interest, not daily short sale volume (flow). Because this data is based on the September 15 settlement date, it reflects positions held as of that time. Investors should cross-reference this with real-time borrow fee data to determine if the trend has continued or if shorts are beginning to cover their positions in the current market environment.
Signal data sourced from StockTitan. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.